Loading...
Novel Oral Anticoagulant Use Among Patients with Atrial Fibrillation Hospitalized with Ischemic Stroke or Transient Ischemic Attack
BACKGROUND: Novel oral anticoagulants (NOACs) have been shown to be at least as good as warfarin for preventing stroke or transient ischemic attack (TIA) in patients with atrial fibrillation (AF), yet diffusion of these therapies and patterns of use among AF patients with ischemic stroke and TIA hav...
Na minha lista:
| Udgivet i: | Circ Cardiovasc Qual Outcomes |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4512906/ https://ncbi.nlm.nih.gov/pubmed/26058721 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCOUTCOMES.114.000907 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|